LUMERIS PHARMACEUTICALS PRIVATE LIMITED is a new, dynamic pharmaceutical company dedicated to discovering, developing, and delivering innovative therapeutic solutions that improve patient outcomes and enhance global health. We are driven by a singular purpose: to leave no patient behind in the journey toward a healthier life.

Focusing on the marketing and distribution of therapeutic medicines. Their core tablet service involves providing combination formulations for chronic conditions, a prime example being the LUMEPRIDE-MV2 tablet.

This product is a crucial triple-drug therapy containing Glimepiride, Metformin Hydrochloride (SR), and Voglibose, and it is specifically indicated for the effective management of Type 2 Diabetes Mellitus.